PB17-026-01

N/A

Report date: 2022/12/15 16:16:25

NME

Base Information

Drug NamePB17-026-01

Drug Alias Name2-((3 R,4R)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl)-5-(2,3-dichlorophenyl)-3-methylpyrrolo[2,1-f][1,2,4]triazin-4(3H)-onePB17-026-01

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 inhibitors

TargetsSrc homology phosphotyrosyl phosphatase 2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesNanjing University Of Chinese Medicine

China Registration ClassN/A

Develop Information

Active CompaniesNanjing University Of Chinese Medicine

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A